WAM
MDGL icon

Wealthspire Advisors (Maryland)’s Madrigal Pharmaceuticals MDGL Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6
Closed -$1K – 1391
2019
Q1 		$1K Hold
6
– – ﹤0.01% 2356
2018
Q4 		$1K Sell
6
-1
-14% -$155 ﹤0.01% 2293
2018
Q3 		$1K Hold
7
– – ﹤0.01% 2297
2018
Q2 		$2K Hold
7
– – ﹤0.01% 2170
2018
Q1 		$1K Sell
7
-1
-13% -$123 ﹤0.01% 2357
2017
Q4 		$1K Hold
8
– – ﹤0.01% 2302
2017
Q3 		$0 Buy
+8
New +$150 ﹤0.01% 2383

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return